Verily logs first major buyout, folding SignalPath trial management system into Baseline platform.

Making good on its pledge to expand the reach of Project Baseline, its clinical research platform, Verily is set to acquire SignalPath, developer of an eponymous platform that, like Baseline, aims to make the entire clinical trial process more efficient. [ABSTRACT FROM AUTHOR]